Literature DB >> 929133

[Transfer factor therapy in a patient with anergic pulmonary tuberculosis].

C H Kind, J C Gartmann, P J Grob.   

Abstract

Report on a patient suffering from severe, relapsing pulmonary tuberculosis showing progressive clinical deterioration accompanied by the appearance of cutaneous anergy to tuberculin. In addition, the sputum cultures showed growth of Mycobacterium intracellulare. During therapy with transferfactorZurich there was a slow but impressive clinical improvement, the skin reactivity to tuberculin was reconstitued and the sputum cultures became negative. The radiological findings remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929133

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

1.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  A placebo controlled clinical trial of transfer factor in lepromatous leprosy.

Authors:  W R Faber; D L Leiker; I M Nengerman; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

3.  Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin.

Authors:  U G Mason; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.